To further evaluate the role of CD8 T cells in the anti‐tumor efficacy of the combination therapy of IR‐TAM@Alb and RT in local solid tumors, the breast fat pad implanted local 4T1 tumors were also used. The gene discussed is CD8A; the disease is neoplasm.